𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A prospective study of escitalopram in the treatment of major depressive episodes in the presence or absence of anxiety

✍ Scribed by Jean-Pierre Olié; Brigitte Tonnoir; François Ménard; André Galinowski


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
141 KB
Volume
24
Category
Article
ISSN
1091-4269

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


How long should a trial of escitalopram
✍ David S. Baldwin; Dan J. Stein; Ornah T. Dolberg; Borwin Bandelow 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## Abstract ## Objective To extend the knowledge of course of improvement in patients with major depressive disorder (MDD), social anxiety disorder (SAD) or generalised anxiety disorder (GAD) participating in randomised placebo‐controlled trials (RCTs) and to infer the optimal duration of initial

Escitalopram in the treatment of general
✍ Jonathan R.T. Davidson; Anjana Bose; Andrew Korotzer; Hongjie Zheng 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Escitalopram has been shown in clinical trials to improve anxiety symptoms associated with depression, panic disorder, and social anxiety disorder. This study was designed to evaluate the efficacy and tolerability of escitalopram in the treatment of generalized anxiety disorder (GAD). Outpatients (1

Transcranial magnetic stimulation (TMS)
✍ Hans Martin Kolbinger; Gereon Höflich; Andreas Hufnagel; Hans-Jürgen Müller; Sie 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB

Transcranial magnetic stimulation (TMS) is a diagnostic method well established in neurology. As some effects of TMS are similar to those of electroconvulsive therapy (ECT), we looked for an antidepressant efficacy of TMS in a semi-blinded monocentric pilot study. Fifteen patients with Major Depress